Published in JAMA Network Open, the research revisits evidence from nine randomized controlled trials involving 1,258 adults with recurrent depression. The participants were generally in partial or full remission when they entered the original studies, meaning they were not experiencing the most severe phase of an acute depressive episode. The researchers used individual participant data rather than relying only on summary results reported in earlier publications. This approach allowed them to examine changes in symptoms for each participant and compare the likelihood of worsening between people assigned to MBCT and those receiving control treatments.

MBCT combines techniques from cognitive behavioral therapy with structured mindfulness practices. Cognitive behavioral therapy helps patients identify patterns of thinking that can intensify emotional distress and teaches strategies for responding to those patterns differently. Mindfulness training, meanwhile, encourages people to observe thoughts, feelings and bodily sensations without immediately judging or reacting to them. In clinical programs, participants typically practice meditation and mindful movement while learning how to recognize early warning signs of relapse. The aim is not to eliminate difficult thoughts, but to reduce the automatic cycles of rumination and avoidance that can contribute to depression.

The treatment became a major focus of depression research after a landmark 2016 meta-analysis combined results from nine studies and supported MBCT as an effective strategy for preventing relapse. A meta-analysis statistically integrates findings from multiple investigations, increasing the amount of evidence available and making it possible to estimate an overall treatment effect. Those earlier findings helped establish MBCT as a recommended option for people with recurrent depression. But the treatment’s growing popularity also prompted a difficult safety question: could intensive attention to distressing thoughts and emotions make some patients feel worse?

That concern was fueled by limited studies in which patients reported harmful or troubling experiences during mindfulness-based interventions. Such reports deserve attention, particularly when an intervention is delivered across healthcare systems and to large populations. However, the earlier studies generally lacked a control group. Without a comparison group, researchers cannot determine whether symptom worsening was caused by the treatment, by the natural course of depression, by unrelated life events or by the difficulties faced by people receiving other forms of care. Depression symptoms can fluctuate even when no intervention is introduced, making controlled comparisons essential for assessing risk.

The new analysis was designed to address that limitation. The researchers reevaluated the original trial data and defined symptom worsening by examining whether participants showed increased depressive symptoms after treatment relative to their starting point and assigned control condition. They then calculated the odds of worsening in the MBCT groups compared with participants who received alternative interventions or control care. Some control groups included people taking antidepressant medication, allowing the investigators to make additional comparisons with a commonly used medical treatment. Because the analysis used data from randomized trials, assignment to MBCT or control conditions was not determined by patients’ preferences or clinicians’ expectations alone, reducing several sources of bias.

The central result was clear: the data provided no evidence that MBCT increased the odds of depressive symptom worsening compared with control conditions. In some secondary analyses, participants assigned to MBCT appeared to have a lower risk of worsening than those receiving other treatments, including antidepressants. These additional findings should be interpreted cautiously because secondary analyses can be affected by differences among the original trials, treatment formats and comparison groups. Nevertheless, the overall pattern did not support the idea that MBCT carries a general risk of worsening depression for the average patient participating in relapse-prevention treatment.

The findings do not mean that every person will benefit from mindfulness practice or that unwanted experiences are impossible. Psychological treatments can affect patients differently, and some people may find meditation uncomfortable, emotionally demanding or difficult to practice without expert guidance. The trials included in this analysis also focused mainly on adults who had recurrent depression but were in partial or full remission. Their results may therefore not apply directly to people experiencing acute, severe depression, individuals with other psychiatric conditions or patients whose symptoms are changing rapidly. Clinicians still need to monitor patients carefully, discuss possible reactions to treatment and provide alternative care when necessary.

Researchers say the next generation of randomized trials should collect a broader range of information about patient experiences, including both benefits and harms. Standard measures of depressive symptoms are important, but they may not capture feelings such as emotional disconnection, heightened anxiety, distress during meditation or changes in day-to-day functioning. More detailed safety monitoring could help identify whether particular patients, practices or delivery settings are associated with different outcomes. It could also distinguish temporary discomfort that resolves with support from clinically meaningful deterioration requiring a change in treatment.

For now, the study strengthens the evidence supporting MBCT as a relapse-prevention option for recurrent depression. Its importance lies not in showing that mindfulness is universally effective, but in testing a specific safety concern with controlled data from more than a thousand participants. As MBCT continues to spread through hospitals, mental health services and community programs, the analysis offers a measured message: available trial evidence does not show that the therapy makes depressive symptoms worse relative to control care, while future research should continue to examine who benefits most, who may struggle and how psychological treatments can be delivered as safely as possible.

Subject of Research: People

Article Title: Symptom Worsening in Mindfulness-Based Cognitive Therapy

News Publication Date: 20-Aug-2026

Web References: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2026.29946 ; https://doi.org/10.1001/jamanetworkopen.2026.29946

References: JAMA Network Open; 2016 meta-analysis indexed at https://pubmed.ncbi.nlm.nih.gov/27119968/; World Health Organization depression fact sheet at https://www.who.int/news-room/fact-sheets/detail/depression

Keywords: Mindfulness-based cognitive therapy, depression, relapse prevention, mental health, meta-analysis, symptom worsening, psychotherapy

Mindfulness-Based Cognitive Therapy is a structured, evidence-based therapeutic intervention that combines principles from cognitive behavioral therapy with mindfulness practices derived originally from Buddhist meditation traditions. It seeks to interrupt ruminative cognitive patterns that often perpetuate depressive episodes by encouraging individuals to cultivate non-judgmental awareness of present moment experiences. While MBCT has shown robust effectiveness in Western contexts, its adaptation and evaluation within diverse cultural frameworks, particularly in Southeast Asia, remain underexplored. The protocol outlined by Weiss and colleagues aims to bridge this gap by operationalizing MBCT in settings symbiotic with Buddhist cultural values.

The trial’s innovative design employs a cluster-randomized methodology, allowing researchers to randomize groups—in this case, pagoda communities—instead of individuals. This approach accounts for potential communal and environmental influences on mental health outcomes, thereby enhancing ecological validity. By implementing MBCT programs within Buddhist pagodas—centers intrinsically linked to mindfulness and contemplative practice—the study leverages an authentic spiritual ambiance that may enhance engagement and acceptance among participants.

Depression continues to be a major public health challenge globally and in Vietnam where access to mental health services faces infrastructural and stigma-related barriers. Integrating MBCT into Buddhist pagoda settings leverages existing community structures and long-standing contemplative traditions, offering a culturally congruent therapeutic modality that could surmount these challenges. The study’s design contemplates both efficacy outcomes and feasibility, addressing critical questions regarding scalability and implementation in real-world conditions, particularly within low- and middle-income countries.

The research protocol includes detailed plans for participant recruitment, inclusion criteria, and standardized outcome assessments. The clusters—groups affiliated with specific pagodas—will be randomized into intervention or control arms, with the latter receiving usual care or alternative supportive measures. This randomization mitigates selection biases and permits rigorous comparison between groups. Assessments of depressive symptomatology will employ validated psychiatric scales and self-report instruments administered at baseline, post-intervention, and follow-up intervals.

Importantly, the intervention’s content is meticulously adapted to respect linguistic and cultural nuances, ensuring that mindfulness exercises, psychoeducation components, and cognitive strategies resonate authentically with Vietnamese participants. This cultural tailoring strives to minimize attrition and enhance therapeutic alliance. The facilitators delivering MBCT will be trained not only in clinical methods but also in cross-cultural competence, ensuring sensitivity and alignment with participants’ spiritual contexts.

From a neuroscientific perspective, mechanisms underlying MBCT’s effectiveness are hypothesized to involve neuroplastic changes within brain regions implicated in emotion regulation, attentional control, and self-referential processing. By enhancing present-moment awareness and detaching individuals from maladaptive cognitive patterns, MBCT may recalibrate neural circuits disrupted in depression. Embedding MBCT in Buddhist settings—where meditation has longstanding empirical and anecdotal support—adds an intriguing dimension to these psychobiological inquiries.

The trial is also positioned to contribute substantially to implementation science. Understanding how mental health interventions can be effectively integrated into non-clinical community settings, particularly religious and spiritual institutions, holds great promise for global mental health initiatives. Buddhist pagodas may serve as sustainable, low-cost platforms for delivering psychological interventions, addressing the pervasive gap between mental health needs and service availability.

Moreover, the research design rigorously incorporates ethical considerations, emphasizing informed consent, confidentiality, and cultural respect. Community leaders and monks from participating pagodas have been involved from the protocol development phase, promoting trust and ownership. This participatory approach is anticipated to improve recruitment and retention rates, while fostering post-trial dissemination and continuity of care.

The expected outcomes from this study could redefine paradigms surrounding mental health service delivery in Vietnam and potentially other Asian contexts, where spiritual traditions are deeply embedded social infrastructures. Should MBCT prove effective within Buddhist pagodas, policy-makers and public health practitioners might consider scaling this model, catalyzing more holistic, culturally embedded approaches to treating depression.

Furthermore, the trial may elucidate specific contextual moderators and mediators of treatment response, such as participants’ baseline religiosity, level of meditation experience, and community cohesion. These insights are invaluable for personalizing and optimizing mindfulness-based interventions across diverse populations, and for advancing theoretical frameworks that integrate cultural psychology with clinical innovation.

The publication of the protocol in a reputable open-access journal like BMC Psychology ensures transparency and encourages scholarly dialogue. By making detailed methodology publicly available prior to conducting the trial, Weiss and colleagues invite critique, replication, and collaborative enhancements that strengthen methodological robustness and ethical rigor in clinical trials addressing mental health in culturally diverse settings.

Anticipation is high in the scientific and global mental health communities for the findings that will emerge from this trailblazing research. It marks a harmonious convergence of traditional meditative wisdom and modern evidence-based practice, embodied in a culturally reverent clinical trial that may offer enduring relief for millions silently suffering from depression.

As mental health care continues to evolve toward integrative and personalized models, studies like this underscore the critical importance of cultural context—a reminder that science does not exist in a vacuum but interacts dynamically with history, belief systems, and community values. The embedding of MBCT in Vietnamese Buddhist pagodas exemplifies how culturally consonant frameworks can catalyze therapeutic engagement and mental wellness.

In conclusion, this ambitious cluster-randomized trial protocol promises to deepen our understanding of how mindfulness-based cognitive therapy can be effectively delivered within indigenous spiritual settings, potentially charting new paths in global mental health intervention strategies. It is a testament to the power of cross-disciplinary and cross-cultural collaboration, uniting neuroscientific rigor with the timeless art of contemplative practice.

Subject of Research: Evaluation of Mindfulness-Based Cognitive Therapy (MBCT) for depression implemented in Vietnamese Buddhist pagodas through a cluster-randomized clinical trial.

Article Title: Protocol for a cluster-randomized clinical trial to evaluate the effectiveness of mindfulness-based cognitive therapy for depression, implemented in Vietnamese Buddhist pagoda.

Article References:
Weiss, B., Vu, V., Dang, HM. et al. Protocol for a cluster-randomized clinical trial to evaluate the effectiveness of mindfulness-based cognitive therapy for depression, implemented in Vietnamese Buddhist pagoda. BMC Psychol 13, 527 (2025). https://doi.org/10.1186/s40359-025-02754-5

Image Credits: AI Generated